An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2015
At a glance
- Drugs Capecitabine (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- Sponsors Roche
- 06 Jul 2012 Actual patient number is 230 according to ClinicalTrials.gov.
- 06 Jul 2012 Planned End Date changed from 1 Apr 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.